Evidence-Based Reviews

Update on bipolar disorder: How to better predict response to maintenance therapy

Current Psychiatry. 2002 April;1(4):40-47

References

1. Solomon DA, Keitner GI, Miller IW, et al. Course of illness and maintenance treatments for patients with bipolar disorder. J Clin Psychiatry 1995;56:5-13.

2. Keck PE, Jr, McElroy SL, et al. Twelve-month outcome of bipolar patients following hospitalization for a manic or mixed episode. Am J Psychiatry 1998;155:646-52.

3. Sachs GS, Printz DJ, et al. The Expert Consensus Guideline Series: medication treatment of bipolar disorders 2000. Postgrad Med Special Report 2000;4:1-104.

4. Sachs GS, Thase ME. Bipolar disorder therapeutics: maintenance treatment. Biol Psychiatry 2000;48:573-81.

5. Keck PE, Jr, Welge JA, et al. Placebo effect in randomized, controlled maintenance studies of patients with bipolar disorder. Biol Psychiatry 2000;47:756-65.

6. Calabrese JR, Rapport DJ, Shelton MD, et al. Evolving methodologies in bipolar disorder maintenance research. Br J Psychiatry 2001;178 [Suppl 41]:157-63.

7. Bowden CL, Calabrese JR, McElroy SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 2000;57:481-9.

8. Calabrese JR, Bowden CL, DeVeaugh-Geiss J, et al. Lamotrigine demonstrates long term mood stabilization in recently manic patients. Lamictal 606 Study Group [Abstract]. Presented at the Annual Meeting of the American Psychiatric Association Meeting, New Orleans, LA, May 5-10, 2001.

9. Denicoff KD, et al. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 1997;58:470-8.

10. Greil W, et al. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders—a randomized study. J Affect Disord 1997;43:151-61.

11. Hirschfeld RMA, Bowden CL, Gitlin MJ, et al. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry, in press.

12. Tohen M, Baker R. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Presented at the Annual Meeting of the American Psychiatric Association. New Orleans, La, May 5-10, 2001.

13. Lambert PA, Venaud G. Comparative study of valpromide versus lithium as prophylactic treatment in affective disorders. Nervure J Psychiatrie 1982;4:1-9.

14. Revicki DA, Hirschfeld RMA, Keck PE, Jr, et al. Cost-effectiveness of divalproex sodium vs. lithium in long-term therapy for bipolar disorder. Presented at the Annual Meeting of the American College of Neuropsychopharmacology. San Juan, Puerto Rico, Dec. 13-17, 1999.

15. Dardennnes R, Even C, et al. Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorders. A meta-analysis. Br J Psychiatry 1995;166:375-81.

16. Calabrese JR, Suppes T, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 2000;61:841-50.

17. Calabrese JR, Bowden CL, Sachs GS, et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999;60:79-88.

18. Frye MA, Ketter TA, Kimbrell TA, et al. A double-blind, placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000;24:133-40.

19. Tohen M. Olanazpine versus placebo in the treatment of acute bipolar mania. Presented at the XI World Congress of Psychiatry, World Psychiatric Association. Hamburg, Germany, Aug. 7, 1999.

20. Suppes T, Webb A, Paul B, et al. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 1999;156:1164-9.

21. Keck PE, Jr, McElroy SL. Pharmacological treatment of bipolar disorder. In: Nathan PE, Gorman JM, eds. A Guide to Treatments that Work. New York: Oxford University Press, 2001, in press.

22. Keck PE, Jr, Licht R. Antipsychotic medications in the treatment of mood disorders. In: Buckley PF, Waddington JL, eds. Schizophrenia and Mood Disorders: The New Drug Therapies in Clinical Practice. Boston: Butterworth-Heiman, 2000;199-211.

23. Gelenberg AJ, Kane JM, et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 1989;321:1489-93.

24. Judd LL, Akiskal HS. Delineating the longitudinal structure of depressive illness: beyond clinical subtypes and duration thresholds. Pharmacopsychiatry 2000;33:3-7.

25. Goodnick PJ, Fieve RR, Schlegel A, et al. Inter-episode major and subclinical symptoms in affective disorder. Acta Psychiatr Scand 1987;75:592-600.

26. Keller MB, Lavori PW, et al. Subsyndromal symptoms in bipolar disorder: a comparison of standard and low serum lithium levels. Arch Gen Psychiatry 1992;49:371-6.

27. Post RM, Altshuler LL, Frye MA, et al. Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. Bipolar Disorders 2001;3:259-65.

28. Solomon DA, Ryan CE, Keitner GI, et al. A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder. J Clin Psychiatry 1997;58:95-9.